nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.059	0.301	CbGbCtD
Paliperidone—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0271	0.138	CbGbCtD
Paliperidone—HTR1D—meninx—peripheral nervous system neoplasm	0.0256	0.131	CbGeAlD
Paliperidone—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0248	0.127	CbGbCtD
Paliperidone—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0247	0.126	CbGbCtD
Paliperidone—HTR1B—dura mater—peripheral nervous system neoplasm	0.0244	0.124	CbGeAlD
Paliperidone—HTR1D—dura mater—peripheral nervous system neoplasm	0.0236	0.12	CbGeAlD
Paliperidone—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.023	0.117	CbGbCtD
Paliperidone—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.0138	0.0702	CbGeAlD
Paliperidone—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0106	0.0539	CbGbCtD
Paliperidone—HTR1B—trigeminal nerve—peripheral nervous system neoplasm	0.0105	0.0534	CbGeAlD
Paliperidone—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0104	0.053	CbGbCtD
Paliperidone—HTR1D—trigeminal nerve—peripheral nervous system neoplasm	0.0101	0.0517	CbGeAlD
Paliperidone—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00968	0.0494	CbGbCtD
Paliperidone—HTR1B—cranial nerve—peripheral nervous system neoplasm	0.00747	0.038	CbGeAlD
Paliperidone—HTR1D—cranial nerve—peripheral nervous system neoplasm	0.00723	0.0368	CbGeAlD
Paliperidone—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0066	0.0337	CbGbCtD
Paliperidone—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00504	0.0257	CbGeAlD
Paliperidone—DRD1—nerve—peripheral nervous system neoplasm	0.00472	0.0241	CbGeAlD
Paliperidone—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00471	0.024	CbGeAlD
Paliperidone—DRD1—ganglion—peripheral nervous system neoplasm	0.00466	0.0238	CbGeAlD
Paliperidone—HTR1B—ganglion—peripheral nervous system neoplasm	0.00378	0.0192	CbGeAlD
Paliperidone—HTR1D—ganglion—peripheral nervous system neoplasm	0.00366	0.0186	CbGeAlD
Paliperidone—HTR2C—ganglion—peripheral nervous system neoplasm	0.00362	0.0185	CbGeAlD
Paliperidone—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00359	0.0183	CbGeAlD
Paliperidone—HTR2A—pons—peripheral nervous system neoplasm	0.00355	0.0181	CbGeAlD
Paliperidone—HTR1A—ganglion—peripheral nervous system neoplasm	0.00305	0.0155	CbGeAlD
Paliperidone—DRD2—nerve—peripheral nervous system neoplasm	0.00279	0.0142	CbGeAlD
Paliperidone—DRD2—ganglion—peripheral nervous system neoplasm	0.00275	0.014	CbGeAlD
Paliperidone—DRD1—brainstem—peripheral nervous system neoplasm	0.00203	0.0103	CbGeAlD
Paliperidone—HTR1B—trigeminal ganglion—peripheral nervous system neoplasm	0.00186	0.00945	CbGeAlD
Paliperidone—HTR2A—nerve—peripheral nervous system neoplasm	0.00184	0.00937	CbGeAlD
Paliperidone—HTR2A—ganglion—peripheral nervous system neoplasm	0.00182	0.00926	CbGeAlD
Paliperidone—HTR1D—trigeminal ganglion—peripheral nervous system neoplasm	0.0018	0.00915	CbGeAlD
Paliperidone—HTR1B—brainstem—peripheral nervous system neoplasm	0.00164	0.00837	CbGeAlD
Paliperidone—HTR1D—brainstem—peripheral nervous system neoplasm	0.00159	0.0081	CbGeAlD
Paliperidone—HTR2C—brainstem—peripheral nervous system neoplasm	0.00157	0.00802	CbGeAlD
Paliperidone—HTR1A—brainstem—peripheral nervous system neoplasm	0.00133	0.00675	CbGeAlD
Paliperidone—ADRA2C—trigeminal ganglion—peripheral nervous system neoplasm	0.00132	0.0067	CbGeAlD
Paliperidone—ADRA2C—parotid gland—peripheral nervous system neoplasm	0.00124	0.00632	CbGeAlD
Paliperidone—ADRA1A—brainstem—peripheral nervous system neoplasm	0.00122	0.00622	CbGeAlD
Paliperidone—DRD2—brainstem—peripheral nervous system neoplasm	0.0012	0.0061	CbGeAlD
Paliperidone—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.00107	0.00544	CbGeAlD
Paliperidone—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.00105	0.00535	CbGeAlD
Paliperidone—HTR2A—brainstem—peripheral nervous system neoplasm	0.00079	0.00402	CbGeAlD
Paliperidone—CYP2D6—brainstem—peripheral nervous system neoplasm	0.00072	0.00367	CbGeAlD
Paliperidone—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000653	0.00333	CbGeAlD
Paliperidone—ADRA1A—cerebellum—peripheral nervous system neoplasm	0.000602	0.00307	CbGeAlD
Paliperidone—DRD2—cerebellum—peripheral nervous system neoplasm	0.00059	0.00301	CbGeAlD
Paliperidone—ADRA2C—cerebellum—peripheral nervous system neoplasm	0.000574	0.00292	CbGeAlD
Paliperidone—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.000458	0.00233	CbGeAlD
Paliperidone—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000389	0.00198	CbGeAlD
Paliperidone—Risperidone—ABCB1—peripheral nervous system neoplasm	0.000387	1	CrCbGaD
Paliperidone—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000355	0.00181	CbGeAlD
Paliperidone—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000359	CcSEcCtD
Paliperidone—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000358	CcSEcCtD
Paliperidone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000193	0.000358	CcSEcCtD
Paliperidone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000192	0.000357	CcSEcCtD
Paliperidone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000191	0.000354	CcSEcCtD
Paliperidone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00019	0.000353	CcSEcCtD
Paliperidone—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000353	CcSEcCtD
Paliperidone—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000352	CcSEcCtD
Paliperidone—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000351	CcSEcCtD
Paliperidone—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000189	0.000351	CcSEcCtD
Paliperidone—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000188	0.00035	CcSEcCtD
Paliperidone—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000188	0.00035	CcSEcCtD
Paliperidone—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000188	0.000349	CcSEcCtD
Paliperidone—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000348	CcSEcCtD
Paliperidone—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000346	CcSEcCtD
Paliperidone—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000346	CcSEcCtD
Paliperidone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000186	0.000346	CcSEcCtD
Paliperidone—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000345	CcSEcCtD
Paliperidone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000186	0.000345	CcSEcCtD
Paliperidone—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000185	0.000343	CcSEcCtD
Paliperidone—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000184	0.000342	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000183	0.00034	CcSEcCtD
Paliperidone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000183	0.00034	CcSEcCtD
Paliperidone—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000183	0.000339	CcSEcCtD
Paliperidone—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000337	CcSEcCtD
Paliperidone—Constipation—Etoposide—peripheral nervous system neoplasm	0.000181	0.000337	CcSEcCtD
Paliperidone—Pain—Etoposide—peripheral nervous system neoplasm	0.000181	0.000337	CcSEcCtD
Paliperidone—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000336	CcSEcCtD
Paliperidone—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000336	CcSEcCtD
Paliperidone—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000336	CcSEcCtD
Paliperidone—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000336	CcSEcCtD
Paliperidone—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000334	CcSEcCtD
Paliperidone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00018	0.000334	CcSEcCtD
Paliperidone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000179	0.000333	CcSEcCtD
Paliperidone—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000332	CcSEcCtD
Paliperidone—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000327	CcSEcCtD
Paliperidone—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000327	CcSEcCtD
Paliperidone—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000326	CcSEcCtD
Paliperidone—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000325	CcSEcCtD
Paliperidone—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000325	CcSEcCtD
Paliperidone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000175	0.000324	CcSEcCtD
Paliperidone—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000324	CcSEcCtD
Paliperidone—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000174	0.000323	CcSEcCtD
Paliperidone—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000323	CcSEcCtD
Paliperidone—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000322	CcSEcCtD
Paliperidone—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000173	0.000322	CcSEcCtD
Paliperidone—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000173	0.000321	CcSEcCtD
Paliperidone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000173	0.000321	CcSEcCtD
Paliperidone—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.00032	CcSEcCtD
Paliperidone—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.00032	CcSEcCtD
Paliperidone—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000171	0.000318	CcSEcCtD
Paliperidone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000171	0.000318	CcSEcCtD
Paliperidone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00017	0.000317	CcSEcCtD
Paliperidone—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000316	CcSEcCtD
Paliperidone—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00017	0.000316	CcSEcCtD
Paliperidone—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000168	0.000313	CcSEcCtD
Paliperidone—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000312	CcSEcCtD
Paliperidone—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000311	CcSEcCtD
Paliperidone—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000168	0.000311	CcSEcCtD
Paliperidone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000168	0.000311	CcSEcCtD
Paliperidone—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000311	CcSEcCtD
Paliperidone—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000311	CcSEcCtD
Paliperidone—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000309	CcSEcCtD
Paliperidone—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000166	0.000309	CcSEcCtD
Paliperidone—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000166	0.000308	CcSEcCtD
Paliperidone—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000307	CcSEcCtD
Paliperidone—Rash—Vincristine—peripheral nervous system neoplasm	0.000165	0.000306	CcSEcCtD
Paliperidone—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000165	0.000306	CcSEcCtD
Paliperidone—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000306	CcSEcCtD
Paliperidone—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000305	CcSEcCtD
Paliperidone—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000304	CcSEcCtD
Paliperidone—Headache—Vincristine—peripheral nervous system neoplasm	0.000164	0.000304	CcSEcCtD
Paliperidone—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000303	CcSEcCtD
Paliperidone—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000302	CcSEcCtD
Paliperidone—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.0003	CcSEcCtD
Paliperidone—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000161	0.0003	CcSEcCtD
Paliperidone—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000299	CcSEcCtD
Paliperidone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000158	0.000294	CcSEcCtD
Paliperidone—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000293	CcSEcCtD
Paliperidone—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000156	0.00029	CcSEcCtD
Paliperidone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000156	0.00029	CcSEcCtD
Paliperidone—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000156	0.00029	CcSEcCtD
Paliperidone—Nausea—Vincristine—peripheral nervous system neoplasm	0.000155	0.000289	CcSEcCtD
Paliperidone—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000288	CcSEcCtD
Paliperidone—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000288	CcSEcCtD
Paliperidone—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000288	CcSEcCtD
Paliperidone—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000286	CcSEcCtD
Paliperidone—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000284	CcSEcCtD
Paliperidone—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000283	CcSEcCtD
Paliperidone—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000152	0.000282	CcSEcCtD
Paliperidone—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000282	CcSEcCtD
Paliperidone—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000282	CcSEcCtD
Paliperidone—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000282	CcSEcCtD
Paliperidone—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000281	CcSEcCtD
Paliperidone—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000151	0.00028	CcSEcCtD
Paliperidone—Chills—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000279	CcSEcCtD
Paliperidone—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00015	0.000279	CcSEcCtD
Paliperidone—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000274	CcSEcCtD
Paliperidone—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000147	0.000273	CcSEcCtD
Paliperidone—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000272	CcSEcCtD
Paliperidone—Rash—Cisplatin—peripheral nervous system neoplasm	0.000146	0.000271	CcSEcCtD
Paliperidone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000146	0.000271	CcSEcCtD
Paliperidone—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000146	0.00027	CcSEcCtD
Paliperidone—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000146	0.00027	CcSEcCtD
Paliperidone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000145	0.000269	CcSEcCtD
Paliperidone—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000269	CcSEcCtD
Paliperidone—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000268	CcSEcCtD
Paliperidone—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000267	CcSEcCtD
Paliperidone—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000267	CcSEcCtD
Paliperidone—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000266	CcSEcCtD
Paliperidone—Tension—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000265	CcSEcCtD
Paliperidone—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000265	CcSEcCtD
Paliperidone—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000263	CcSEcCtD
Paliperidone—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000262	CcSEcCtD
Paliperidone—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000261	CcSEcCtD
Paliperidone—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00014	0.00026	CcSEcCtD
Paliperidone—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.00014	0.00026	CcSEcCtD
Paliperidone—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.00026	CcSEcCtD
Paliperidone—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000259	CcSEcCtD
Paliperidone—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000258	CcSEcCtD
Paliperidone—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000137	0.000255	CcSEcCtD
Paliperidone—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000255	CcSEcCtD
Paliperidone—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000254	CcSEcCtD
Paliperidone—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000252	CcSEcCtD
Paliperidone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000251	CcSEcCtD
Paliperidone—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000135	0.00025	CcSEcCtD
Paliperidone—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.00025	CcSEcCtD
Paliperidone—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.00025	CcSEcCtD
Paliperidone—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000135	0.00025	CcSEcCtD
Paliperidone—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000248	CcSEcCtD
Paliperidone—Rash—Etoposide—peripheral nervous system neoplasm	0.000134	0.000248	CcSEcCtD
Paliperidone—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000134	0.000248	CcSEcCtD
Paliperidone—Headache—Etoposide—peripheral nervous system neoplasm	0.000133	0.000247	CcSEcCtD
Paliperidone—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000247	CcSEcCtD
Paliperidone—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000246	CcSEcCtD
Paliperidone—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000245	CcSEcCtD
Paliperidone—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000244	CcSEcCtD
Paliperidone—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000243	CcSEcCtD
Paliperidone—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000243	CcSEcCtD
Paliperidone—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000242	CcSEcCtD
Paliperidone—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000242	CcSEcCtD
Paliperidone—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000242	CcSEcCtD
Paliperidone—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000241	CcSEcCtD
Paliperidone—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000239	CcSEcCtD
Paliperidone—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000238	CcSEcCtD
Paliperidone—Cough—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000236	CcSEcCtD
Paliperidone—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000236	CcSEcCtD
Paliperidone—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000234	CcSEcCtD
Paliperidone—Nausea—Etoposide—peripheral nervous system neoplasm	0.000126	0.000234	CcSEcCtD
Paliperidone—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000233	CcSEcCtD
Paliperidone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000232	CcSEcCtD
Paliperidone—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000231	CcSEcCtD
Paliperidone—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000124	0.00023	CcSEcCtD
Paliperidone—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000124	0.00023	CcSEcCtD
Paliperidone—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000124	0.00023	CcSEcCtD
Paliperidone—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.00023	CcSEcCtD
Paliperidone—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000229	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000229	CcSEcCtD
Paliperidone—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000227	CcSEcCtD
Paliperidone—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000226	CcSEcCtD
Paliperidone—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000225	CcSEcCtD
Paliperidone—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000225	CcSEcCtD
Paliperidone—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000224	CcSEcCtD
Paliperidone—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000224	CcSEcCtD
Paliperidone—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000223	CcSEcCtD
Paliperidone—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000221	CcSEcCtD
Paliperidone—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000221	CcSEcCtD
Paliperidone—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000221	CcSEcCtD
Paliperidone—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.00022	CcSEcCtD
Paliperidone—Infection—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000219	CcSEcCtD
Paliperidone—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000218	CcSEcCtD
Paliperidone—Shock—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000217	CcSEcCtD
Paliperidone—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000217	CcSEcCtD
Paliperidone—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000216	CcSEcCtD
Paliperidone—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000216	CcSEcCtD
Paliperidone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000216	CcSEcCtD
Paliperidone—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000215	CcSEcCtD
Paliperidone—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000214	CcSEcCtD
Paliperidone—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000213	CcSEcCtD
Paliperidone—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000213	CcSEcCtD
Paliperidone—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000213	CcSEcCtD
Paliperidone—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000212	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000212	CcSEcCtD
Paliperidone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.00021	CcSEcCtD
Paliperidone—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000113	0.00021	CcSEcCtD
Paliperidone—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000208	CcSEcCtD
Paliperidone—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000206	CcSEcCtD
Paliperidone—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000206	CcSEcCtD
Paliperidone—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000204	CcSEcCtD
Paliperidone—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000204	CcSEcCtD
Paliperidone—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000203	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000201	CcSEcCtD
Paliperidone—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000201	CcSEcCtD
Paliperidone—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.0002	CcSEcCtD
Paliperidone—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.0002	CcSEcCtD
Paliperidone—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000107	0.0002	CcSEcCtD
Paliperidone—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000199	CcSEcCtD
Paliperidone—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000198	CcSEcCtD
Paliperidone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000198	CcSEcCtD
Paliperidone—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000197	CcSEcCtD
Paliperidone—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000196	CcSEcCtD
Paliperidone—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000195	CcSEcCtD
Paliperidone—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000194	CcSEcCtD
Paliperidone—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000192	CcSEcCtD
Paliperidone—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000191	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000191	CcSEcCtD
Paliperidone—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000102	0.00019	CcSEcCtD
Paliperidone—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000189	CcSEcCtD
Paliperidone—Pain—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000189	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000186	CcSEcCtD
Paliperidone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	9.94e-05	0.000185	CcSEcCtD
Paliperidone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	9.87e-05	0.000183	CcSEcCtD
Paliperidone—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	9.8e-05	0.000182	CcSEcCtD
Paliperidone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	9.79e-05	0.000182	CcSEcCtD
Paliperidone—Somnolence—Doxorubicin—peripheral nervous system neoplasm	9.77e-05	0.000182	CcSEcCtD
Paliperidone—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	9.72e-05	0.00018	CcSEcCtD
Paliperidone—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	9.68e-05	0.00018	CcSEcCtD
Paliperidone—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	9.56e-05	0.000177	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	9.49e-05	0.000176	CcSEcCtD
Paliperidone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	9.48e-05	0.000176	CcSEcCtD
Paliperidone—Urticaria—Epirubicin—peripheral nervous system neoplasm	9.44e-05	0.000175	CcSEcCtD
Paliperidone—Constipation—Doxorubicin—peripheral nervous system neoplasm	9.4e-05	0.000175	CcSEcCtD
Paliperidone—Pain—Doxorubicin—peripheral nervous system neoplasm	9.4e-05	0.000175	CcSEcCtD
Paliperidone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	9.39e-05	0.000174	CcSEcCtD
Paliperidone—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	9.39e-05	0.000174	CcSEcCtD
Paliperidone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	9.06e-05	0.000168	CcSEcCtD
Paliperidone—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	8.99e-05	0.000167	CcSEcCtD
Paliperidone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	8.75e-05	0.000163	CcSEcCtD
Paliperidone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	8.73e-05	0.000162	CcSEcCtD
Paliperidone—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	8.69e-05	0.000161	CcSEcCtD
Paliperidone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	8.69e-05	0.000161	CcSEcCtD
Paliperidone—Asthenia—Epirubicin—peripheral nervous system neoplasm	8.52e-05	0.000158	CcSEcCtD
Paliperidone—Pruritus—Epirubicin—peripheral nervous system neoplasm	8.41e-05	0.000156	CcSEcCtD
Paliperidone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	8.13e-05	0.000151	CcSEcCtD
Paliperidone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	8.1e-05	0.00015	CcSEcCtD
Paliperidone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	7.89e-05	0.000146	CcSEcCtD
Paliperidone—Dizziness—Epirubicin—peripheral nervous system neoplasm	7.86e-05	0.000146	CcSEcCtD
Paliperidone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	7.78e-05	0.000144	CcSEcCtD
Paliperidone—Vomiting—Epirubicin—peripheral nervous system neoplasm	7.55e-05	0.00014	CcSEcCtD
Paliperidone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	7.52e-05	0.00014	CcSEcCtD
Paliperidone—Rash—Epirubicin—peripheral nervous system neoplasm	7.49e-05	0.000139	CcSEcCtD
Paliperidone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	7.48e-05	0.000139	CcSEcCtD
Paliperidone—Headache—Epirubicin—peripheral nervous system neoplasm	7.44e-05	0.000138	CcSEcCtD
Paliperidone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.27e-05	0.000135	CcSEcCtD
Paliperidone—Nausea—Epirubicin—peripheral nervous system neoplasm	7.06e-05	0.000131	CcSEcCtD
Paliperidone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.99e-05	0.00013	CcSEcCtD
Paliperidone—Rash—Doxorubicin—peripheral nervous system neoplasm	6.93e-05	0.000129	CcSEcCtD
Paliperidone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.92e-05	0.000129	CcSEcCtD
Paliperidone—Headache—Doxorubicin—peripheral nervous system neoplasm	6.89e-05	0.000128	CcSEcCtD
Paliperidone—Nausea—Doxorubicin—peripheral nervous system neoplasm	6.53e-05	0.000121	CcSEcCtD
Paliperidone—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	2.43e-05	0.000352	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.43e-05	0.000352	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.4e-05	0.000347	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.36e-05	0.000342	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.36e-05	0.000342	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.35e-05	0.00034	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.32e-05	0.000336	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	2.29e-05	0.000331	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.29e-05	0.000331	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.28e-05	0.00033	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.25e-05	0.000326	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.25e-05	0.000325	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.24e-05	0.000324	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	2.21e-05	0.00032	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.2e-05	0.000319	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.2e-05	0.000318	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.18e-05	0.000315	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.17e-05	0.000314	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.16e-05	0.000313	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.16e-05	0.000312	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.14e-05	0.00031	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.14e-05	0.00031	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	2.12e-05	0.000307	CbGpPWpGaD
Paliperidone—ADRA2B—Hemostasis—TP53—peripheral nervous system neoplasm	2.12e-05	0.000307	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	2.1e-05	0.000304	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.1e-05	0.000304	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.1e-05	0.000304	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.08e-05	0.0003	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.07e-05	0.000299	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.06e-05	0.000298	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	2.05e-05	0.000297	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.04e-05	0.000296	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	2.04e-05	0.000295	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	2.04e-05	0.000295	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.04e-05	0.000295	CbGpPWpGaD
Paliperidone—ADRA2B—Hemostasis—HRAS—peripheral nervous system neoplasm	2.03e-05	0.000293	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.02e-05	0.000293	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.01e-05	0.000292	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.01e-05	0.00029	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	2e-05	0.00029	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2e-05	0.00029	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.98e-05	0.000287	CbGpPWpGaD
Paliperidone—ADRA2C—Hemostasis—TP53—peripheral nervous system neoplasm	1.98e-05	0.000287	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.98e-05	0.000286	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.95e-05	0.000282	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.95e-05	0.000282	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.9e-05	0.000276	CbGpPWpGaD
Paliperidone—ADRA2C—Hemostasis—HRAS—peripheral nervous system neoplasm	1.89e-05	0.000274	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.87e-05	0.000271	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.87e-05	0.000271	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	1.87e-05	0.00027	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.86e-05	0.000269	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.83e-05	0.000266	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	1.83e-05	0.000265	CbGpPWpGaD
Paliperidone—ADRA2B—Hemostasis—AKT1—peripheral nervous system neoplasm	1.79e-05	0.000259	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.78e-05	0.000258	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.76e-05	0.000255	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.75e-05	0.000254	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	1.73e-05	0.000251	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.73e-05	0.00025	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.7e-05	0.000247	CbGpPWpGaD
Paliperidone—ADRA2C—Hemostasis—AKT1—peripheral nervous system neoplasm	1.67e-05	0.000242	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.65e-05	0.000239	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	1.63e-05	0.000236	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	1.61e-05	0.000233	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.6e-05	0.000231	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.59e-05	0.00023	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.56e-05	0.000226	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.56e-05	0.000226	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.54e-05	0.000223	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	1.54e-05	0.000223	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.53e-05	0.000222	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.53e-05	0.000221	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.51e-05	0.000218	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.5e-05	0.000218	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.5e-05	0.000217	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.48e-05	0.000215	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.47e-05	0.000213	CbGpPWpGaD
Paliperidone—HTR1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.46e-05	0.000212	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.46e-05	0.000212	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.46e-05	0.000211	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.45e-05	0.00021	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.45e-05	0.00021	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.44e-05	0.000208	CbGpPWpGaD
Paliperidone—HTR1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.43e-05	0.000207	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.42e-05	0.000206	CbGpPWpGaD
Paliperidone—DRD4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.41e-05	0.000204	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.4e-05	0.000202	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.39e-05	0.000201	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.37e-05	0.000198	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	1.36e-05	0.000197	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.35e-05	0.000195	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.34e-05	0.000194	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.33e-05	0.000192	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.33e-05	0.000192	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.33e-05	0.000192	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.32e-05	0.000192	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.32e-05	0.000191	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.3e-05	0.000189	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.3e-05	0.000189	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.3e-05	0.000189	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.3e-05	0.000188	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.3e-05	0.000188	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.3e-05	0.000188	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.29e-05	0.000186	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.28e-05	0.000185	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.27e-05	0.000185	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.27e-05	0.000184	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.26e-05	0.000182	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.25e-05	0.000181	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.24e-05	0.00018	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.23e-05	0.000179	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.21e-05	0.000176	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.21e-05	0.000175	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.19e-05	0.000172	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.19e-05	0.000172	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.18e-05	0.000172	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.18e-05	0.000172	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.17e-05	0.00017	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.16e-05	0.000168	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.15e-05	0.000167	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.15e-05	0.000167	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.14e-05	0.000165	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.13e-05	0.000164	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.13e-05	0.000164	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.13e-05	0.000164	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.13e-05	0.000164	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.12e-05	0.000163	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.12e-05	0.000162	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.12e-05	0.000162	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.11e-05	0.00016	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.09e-05	0.000158	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.09e-05	0.000158	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.09e-05	0.000157	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.09e-05	0.000157	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.08e-05	0.000157	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.08e-05	0.000156	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.08e-05	0.000156	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.07e-05	0.000155	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.06e-05	0.000154	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.06e-05	0.000153	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.05e-05	0.000153	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.05e-05	0.000151	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.05e-05	0.000151	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.04e-05	0.000151	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.04e-05	0.00015	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.03e-05	0.000149	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.03e-05	0.000149	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.03e-05	0.000149	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.03e-05	0.000149	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.01e-05	0.000146	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.91e-06	0.000143	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.86e-06	0.000143	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.85e-06	0.000143	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.82e-06	0.000142	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.69e-06	0.00014	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.68e-06	0.00014	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.67e-06	0.00014	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.59e-06	0.000139	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.58e-06	0.000139	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.49e-06	0.000137	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.49e-06	0.000137	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.44e-06	0.000137	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.43e-06	0.000137	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.41e-06	0.000136	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.39e-06	0.000136	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.36e-06	0.000136	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.34e-06	0.000135	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.32e-06	0.000135	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.29e-06	0.000135	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.23e-06	0.000134	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.14e-06	0.000132	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.1e-06	0.000132	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.06e-06	0.000131	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.01e-06	0.000131	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.95e-06	0.00013	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.89e-06	0.000129	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.82e-06	0.000128	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.77e-06	0.000127	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.74e-06	0.000127	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.7e-06	0.000126	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.7e-06	0.000126	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	8.68e-06	0.000126	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.63e-06	0.000125	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.58e-06	0.000124	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.56e-06	0.000124	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.56e-06	0.000124	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.54e-06	0.000124	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	8.52e-06	0.000123	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.5e-06	0.000123	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.44e-06	0.000122	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.4e-06	0.000122	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.38e-06	0.000121	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.17e-06	0.000118	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.06e-06	0.000117	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.04e-06	0.000116	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.96e-06	0.000115	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.95e-06	0.000115	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.85e-06	0.000114	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.83e-06	0.000113	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.81e-06	0.000113	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.79e-06	0.000113	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.71e-06	0.000112	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.68e-06	0.000111	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.66e-06	0.000111	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.61e-06	0.00011	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.56e-06	0.000109	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.41e-06	0.000107	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.29e-06	0.000106	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.28e-06	0.000105	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.18e-06	0.000104	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.14e-06	0.000103	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.12e-06	0.000103	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.93e-06	0.0001	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.9e-06	9.99e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.87e-06	9.94e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.81e-06	9.86e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—AKT1—peripheral nervous system neoplasm	6.77e-06	9.81e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.72e-06	9.73e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.71e-06	9.71e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.63e-06	9.61e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.63e-06	9.6e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.6e-06	9.56e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.59e-06	9.55e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.41e-06	9.29e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.31e-06	9.14e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.09e-06	8.81e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.06e-06	8.78e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.99e-06	8.67e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.98e-06	8.65e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.86e-06	8.49e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.85e-06	8.48e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.82e-06	8.43e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.82e-06	8.43e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.73e-06	8.29e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.71e-06	8.28e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.66e-06	8.2e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.61e-06	8.12e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.57e-06	8.07e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	5.5e-06	7.97e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.45e-06	7.89e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.21e-06	7.55e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.14e-06	7.44e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.06e-06	7.32e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.05e-06	7.31e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	5.04e-06	7.3e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.95e-06	7.17e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.6e-06	6.66e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	3.59e-06	5.19e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	2.34e-06	3.39e-05	CbGpPWpGaD
